Swedish Machinery Stock News

AlzeCure Pharma shares came into this earnings print on a sharp upswing, with a very large 90 day gain that set expectations high. The stock now trades at a premium P/E of 34.5x, which already prices in a cleaner story than most European pharma peers. The headline this quarter is blunt. AlzeCure moved from repeated quarterly losses to a profitable Q2, with basic earnings per share of 0.70 SEK on total revenue of 97.33 million SEK, and that shift is what is really testing investor conviction...

Systemair stock has been quietly grinding higher, with a 90‑day gain of about 16%, and closed at SEK88 just as the latest earnings landed. The immediate question for you is whether that move already reflects the story or if the results reset the debate. The headline this season is margin power. Net profit margin over the last 12 months reached 6.1% compared with 5.5% a year earlier while earnings grew 11.8% and now sit against a reported P/E of 24x. The rest of this report unpacks what that...

Ambea (OM:AMBEA) is back in focus after its second quarter 2026 report, which combined higher revenue and net income with fresh commentary on ongoing acquisitions and an active pipeline of bolt on deals. Against this backdrop, Ambea’s share price has gained 21.72% over the past month and 25.14% year to date, with the current share price at SEK173.7. A 1 year total shareholder return of 38.74% and a very large 3 year total shareholder return suggest that momentum has been building as investors...

Alleima (OM:ALLEI) is in focus after two closely timed updates. The company extended its long partnership with Airbus around titanium seamless tubes and committed to a SEK 220 million tubing capacity investment in India. These announcements appear to sit alongside a strong recent run in Alleima’s shares, with a 90 day share price return of 42.57% and a year to date share price return of 45.73%, while the 1 year total shareholder return of 79.32% points to strong momentum building rather than...

Cereno Scientific stock has been grinding lower for months, and today investors had to decide whether another biotech loss story deserves a premium P/S of 20.6x. The headline is blunt. Revenue for Q2 2026 landed at SEK52.6 million, yet the company still reported a net loss of SEK30.5 million and remains unprofitable over the past year. For a drug developer with less than one year of cash runway and forecasts pointing to no revenue next year, this earnings print is a sentiment test. The...

Inission stock came into this earnings day with a flat short term story and a mixed quarter on the tape. The price closed at SEK72.20 with only modest gains over the past month and a soft 90 day return, even as the latest report showed Q2 revenue of SEK635.4m and basic earnings per share of SEK1.30. The headline is margin repair. Earnings before interest, tax and amortisation stepped up, profit margins improved on the trailing 12 month view and investors now have to decide whether that slow...

Bravida Holding (OM:BRAV) has just secured two new data center installation contracts in Sweden and Denmark, including an approximately SEK 850 million project in Mälardalen. These wins give investors fresh context for assessing the stock. At a share price of SEK136.4, Bravida Holding has delivered a 90 day share price return of nearly 20% and a year to date share price return of about 54%. The 1 year total shareholder return of roughly 55% points to strong momentum that these new data center...

GomSpace Group stock has climbed 6.5% over the past week, yet still sits roughly 42% lower over three months, which shows how weak sentiment was coming into this earnings report. The headline this quarter is simple: the small-satellite specialist is now putting profit on the table, with Q2 net income of SEK 8.2m on revenue of SEK 112.6m and a trailing P/E of 54.6x that reflects substantial expectations for future execution. Impressed that GomSpace Group is now posting a profit but wary of a...

AI driven cyber threats are moving from theory to boardroom priority, and regulators are paying close attention. That mix of urgency and scrutiny is reshaping where budgets flow and which companies win large security and AI security contracts. For investors, it creates a window where strong cybersecurity and AI security providers could gain share while weaker players struggle. This article examines three stocks exposed to that news and explains why their positioning matters at this point. The...

BioArctic stock comes into this earnings print with a flat month, a weak 7 day stretch and a 90 day slide that has chipped away at recent enthusiasm. The market has cooled on the story just as the Q2 numbers land. The headline is simple. A biotech built on rich Leqembi royalty expectations has just posted a small quarterly loss despite SEK 247.5m in revenue and recurring royalties closing in on SEK 200m per quarter. The main question now is how investors price a profit wobble in a business...

The European stock market has recently experienced some turbulence, with the pan-European STOXX Europe 600 Index ending the week down due to global bond sell-offs and inflationary pressures. In this context, penny stocks—typically smaller or newer companies—continue to present intriguing opportunities for investors seeking growth at a lower cost. Despite being an outdated term, penny stocks remain relevant as they can offer significant potential when supported by strong financials and sound...

While CombinedX AB (publ) ( STO:CX ) shareholders have enjoyed a good week with stock up 10%, they need remain...

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Even though FSport AB (publ) ( STO:FSPORT ) stock gained 18% last week, insiders who sold kr7.2m worth of stock over...

We wouldn't blame Cheffelo AB (publ) ( STO:CHEF ) shareholders if they were a little worried about the fact that Olle...

Saab (OM:SAAB B) is in focus after unveiling its A3-001 uncrewed combat air system concept at the Swedish Armed Forces Air Show, raising fresh questions about how this ambition feeds into the stock’s long term story. The A3-001 concept arrives at a time when Saab’s share price has shown firm momentum, with a 30-day share price return of 6.67% and a year-to-date share price return of 14.52%, while the 1-year total shareholder return of 19.86% extends a very strong multi year track...

Zinzino stock has climbed over the past month, yet the latest Q2 print gives investors a more grounded story to weigh. The headline is simple: profitability remains the anchor. Basic earnings per share came in at 2.72 SEK and net income reached 105.642 million SEK on 936.814 million SEK of revenue. That keeps the recent earnings run rate intact rather than blowing expectations away or breaking the equity story. Love that Zinzino is still turning a profit but want to compare it with companies...

Why Embracer Group’s latest earnings and guidance matter for investors Embracer Group (OM:EMBRAC B) has drawn fresh attention after reporting first quarter 2026 results alongside new earnings guidance for the second quarter and full fiscal year 2026 to 2027. The company reported first quarter revenue of SEK 4,006 million compared with SEK 3,261 million a year earlier, and net income of SEK 39 million compared with a net loss of SEK 411 million in the prior year period. At the same time,...

Sandvik (OM:SAND) is back in focus after securing a SEK 275 million underground mining equipment order from Kamoa Copper for the Kamoa Kakula copper mine in the Democratic Republic of the Congo. The Kamoa Kakula order arrives as Sandvik’s share price trades at SEK394.8, with a 7 day share price return of 10.62% and a 30 day share price return of 12.90%. The year to date share price return of 30.82% and 1 year total shareholder return of 66.35% indicate that momentum has been building over...

As European markets navigate the complexities of global bond sell-offs and inflationary pressures, indices like Germany's DAX and France's CAC 40 have experienced declines, while the UK's FTSE 100 showed resilience with a slight gain. In this environment, identifying stocks that may be trading below their estimated value can provide opportunities for investors looking to capitalize on potential market inefficiencies.

European markets have recently faced challenges, with the pan-European STOXX Europe 600 Index experiencing a decline amid global bond sell-offs and inflationary pressures. Despite these broader market uncertainties, penny stocks—often smaller or newer companies—remain an intriguing area for investors seeking potential growth opportunities. While the term 'penny stock' might seem outdated, these investments can still offer significant value when backed by strong financials and growth potential.

Mycronic AB recently announced it received an order worth between US$4 million and US$6 million for an SLX laser mask writer from a new customer in Asia, with delivery planned in the first quarter of 2027. The deal underscores how Mycronic is leveraging its display mask writer technology to meet growing semiconductor photomask demand and replacement needs in Asia. We will now examine how this new Asian SLX order, highlighting demand for semiconductor photomasks, influences Mycronic’s...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

In August 2026, European markets have been navigating a landscape marked by global bond sell-offs and inflationary pressures, with the pan-European STOXX Europe 600 Index experiencing a slight decline. Amid this backdrop of uncertainty, growth companies with high insider ownership can offer unique insights into potential resilience and alignment of interests between stakeholders and management.